Englander Institute for Precision Medicine
Found 917 results
Author Title Type [ Year(Desc)]
Filters: Corrigendum-whole-genome-and-transcriptome-analysis-pancreatic-acinar-cell-carcinoma is   [Clear All Filters]
2026
Okur V, Marcus A, Falcone JN, Hurd MA, Stewart SL, Claudio K, Manohar J, Dealla F, Kumar S, Yeung M et al..  2026.  Genome sequencing identifies monogenic causes in adults with metabolic diseases.. J Endocr Soc. 10(7):bvag091.
Zhang X, Wong W, Cho HS, Yang D, Dixon G, Luo R, Liu D, Torre D, Umeda S, González F et al..  2026.  Human pancreatic progenitor organoids define genetic and epigenetic barriers to early PDAC transformation.. Dev Cell.
Stephan N, Halama A, Thareja G, Sarwath H, Grallert H, Peters A, Gieger C, Schmidt F, Graumann J, Suhre K.  2026.  Identification of Protein Signatures Reflecting Latent Variation in Aptamer-Based Affinity Proteomics.. J Proteome Res.
Uppal M, Bhinder B, Marderstein AR, Batlevi CLee, Falchi L, Hamlin P, Horwitz S, Kumar A, Noy A, Zelenetz AD et al..  2026.  Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.. J Clin Oncol. :JCO2501928.
Ochoa-Cholán V, Miyauchi J, Ohara K, Kosaka T, Mohler JL, Mosquera JMiguel.  2026.  An International Survey Among Attending Urologists on the Term High-Grade Prostatic Intraepithelial Neoplasia: Advocating for Removal of 'High-Grade' From the Surgical Pathology Report.. Int J Urol. 33(6):e70530.
Abrahimi P, Khan JF, Duren-Lubanski A, Cai W, Marouf Y, Chen N, Hirschhorn D, Mammone R, Miranda IC, Tallman JE et al..  2026.  Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.. J Exp Med. 223(7)
Bleve S, Ravera F, Rodrigues S, Pederzoli F, Pakula H, Brighi N, Giunta EFrancesco, Schepisi G, Virga A, Gurioli G et al..  2026.  Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.. Prostate Cancer Prostatic Dis.
Chaudhry F, Kim TWan, Elemento O, Betel D.  2026.  Machine learning analysis of population-wide plasma proteins identifies hormonal biomarkers of Parkinson's disease.. Front Aging Neurosci. 18:1730550.
Oro AE, Amagai M, Payne AS, Ellebrecht C, Hovnanian A, Anandasabapathy N, Leachman SA, Harris-Tryon T.  2026.  Mechanistic insights into emerging therapeutic platforms: The 72nd annual Montagna Symposium on the biology of skin.. J Invest Dermatol.
Anwardeen N, Razzaq A, Elashi AA, Thareja G, Diboun I, Naja K, Suhre K, Elrayess MA.  2026.  Metformin Treatment Potentially Modifies Genetically Driven Metabolite-HbA1c Associations: A Gene-Environment Interaction Mendelian Randomization Study.. Pharmaceuticals (Basel). 19(5)
Grimont A, Falvo DJ, Sisso WJ, Santos F, Chan CW, Zumbo P, Fall WB, Ferrick K, Pan G, Cleveland M et al..  2026.  Molecular dynamics driving phenotypic divergence among KRAS mutants in pancreatic tumorigenesis.. Dev Cell.
Likasitwatanakul P, Blinka SM, Zarka JG, Gebrael G, Weg E, Longoria O, Moore JA, Sharp A, de Bono J, Sternberg CN et al..  2026.  Molecular landscape of prostate cancers with clival metastases.. Oncologist. 31(4)
Toth R, Choi S, Le Naour-Vernet M, Schwanke F, Johnson JL, Tee EE, Yaron-Barir TM, Khochaba E, Derbyshire P, Colo A et al..  2026.  Motif-based substrate mapping of the receptor-like cytoplasmic kinase BIK1 reveals novel components and regulatory nodes of plant immunity.. Nat Plants. 12(2):465-480.
Koprulu M, Smith-Byrne K, Ferolito BRichard, Macdonald-Dunlop E, Luan J'an, Hedman ÅK, Ogamba CFranklin, Kuliesius J, Repetto L, Ramisch A et al..  2026.  Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome.. Cell. 189(11):3339-3357.e11.
Elemento O.  2026.  Multi-Hospital Electronic Health Record Foundation Models Without Data Sharing: A Comparison of Federated Learning and Inference-Time Ensembling.. medRxiv.
Surapaneni S, Kutler RB, Setzen SA, Kim YEun, Yao P, Siddiqui SH, Pitman MJ, Sulica L, Elemento O, Khosravi P et al..  2026.  A Multimodal Approach for Deep-Learning Classification of Vocal Fold Pathologies in Stroboscopy.. Laryngoscope.
Xu C, Us I, Cohen-Setton J, Milo M, Sidders B, Fitzgibbon J, Melnick AM, Pan H, Bulusu KC, Elemento O.  2026.  PAIRWISE: Deep Learning-based Prediction of Effective Personalized Drug Combinations in Cancer.. Res Sq.
Kuo H-H, Bhinder B, Gokozan HN, Gorski K, Chandra P, Manohar J, Guevara D, Otilano J, Moyer J, Tranquille M et al..  2026.  Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.. Sci Adv. 12(26):eadz3351.
Xing Y, Reznikov I, Ahmed ANur, Sidhu I, Wisnewski J, Farhat A, Prystupa A, Konieczny P, Mansfield K, Cooper ML et al..  2026.  Peripheral immune-inducer dendritic cells drive early-life allergic inflammation.. Nature.
De Boni L, Claridge S, Nath S, Tofani K, Stein BD, Park E, Steiner S, Elemento O, Pauli C, Hopkins BD.  2026.  Placing purines in precision medicine: Targeting a metabolic reliance in KRAS-mutant tumors.. iScience. 29(3):114954.
Toth R, Choi S, Le Naour-Vernet M, Schwanke F, Johnson JL, Tee EE, Yaron-Barir TM, Khochaba E, Derbyshire P, Colo A et al..  2026.  Publisher Correction: Motif-based substrate mapping of the receptor-like cytoplasmic kinase BIK1 reveals novel components and regulatory nodes of plant immunity.. Nat Plants. 12(3):666.
Du W, De Boni L, Hopkins BDavid, Elemento O.  2026.  A quantitative approach for defining the degradability landscape of protein degraders.. Nat Commun.
Armstrong AJ, Azad AA, Iguchi T, Stenzl A, Mottet N, Russell D, Rosales M, Haas GP, Saad F, Hussain M et al..  2026.  Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide.. J Clin Oncol. :JCO2402829.
Al-Thani NM, Toor SM, Umlai U-KIsmail, Aliyu U, Suhre K, Albagha OME.  2026.  Refining the Genetic Contribution to Type 2 Diabetes Subtypes.. Diabetes Obes Metab.
Armstrong AJ, Azad AA, Saad F, Hussain M, Iguchi T, Stenzl A, Sternberg CN.  2026.  Reply to: Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide.. J Clin Oncol. :JCO2601500.